Big Cypress Acquisition Corp (BCYP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BCYP | AMGN | VRTX | REGN | BMY |
| Company | Big Cypress Acquisition Corp | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 10.46 | 326.89 | 464.77 | 1,124.75 | 49.12 |
| High | 12.90 | 326.89 | 465.72 | 1,124.75 | 49.14 |
| Low | 8.21 | 323.06 | 462.95 | 1,124.75 | 48.73 |
| Last | 8.44 | 323.23 | 463.70 | 1,130.08 | 48.59 |
| Change | -2.01 | -5.70 | -7.08 | -6.27 | -0.69 |
| % Change | -19.23% | -1.73% | -1.50% | -0.55% | -1.40% |
| Volume | 15,335,100 | 3,474 | 5,301 | 19,382 | 11,208 |
| 20-Day Average Volume | 1,011,805 | 1,592,074 | 988,695 | 407,024 | 8,820,646 |
| Previous Close | 10.45 | 328.93 | 470.78 | 1,136.35 | 49.28 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.02 | 327.03 | 479.06 | 1,173.64 | 49.00 |
| 20-Day Raw Stochastic | 4.90% | 24.37% | 0.13% | 2.50% | 48.51% |
| 20-Day Relative Strength | 26.16% | 48.28% | 41.76% | 48.07% | 54.96% |
| Weighted Alpha | -22.62 | +22.99 | +28.51 | +37.61 | -12.19 |
| Today's Opinion | N/A | 56% Buy | 24% Buy | 72% Buy | 40% Buy |
| Previous Opinion | N/A | 88% Buy | 40% Buy | 80% Buy | 56% Buy |
| Last Month's Opinion | N/A | 72% Buy | 56% Buy | 100% Buy | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.44% since 10/15/21 | -2.29% since 09/04/24 | -3.25% since 09/04/24 | -4.63% since 09/04/24 | -2.40% since 09/04/24 |
| Low | 8.21 on 10/22/21 | 319.00 on 09/06/24 | 462.95 on 09/11/24 | 1,122.53 on 09/10/24 | 47.55 on 09/09/24 |
| High | 12.90 on 10/22/21 | 331.86 on 09/05/24 | 477.73 on 09/05/24 | 1,175.16 on 09/05/24 | 50.24 on 09/05/24 |
| 1-Month | |||||
| %Chg | -15.95% since 09/22/21 | +0.18% since 08/09/24 | -1.16% since 08/09/24 | -0.57% since 08/09/24 | +4.37% since 08/09/24 |
| Low | 8.21 on 10/22/21 | 317.93 on 08/12/24 | 458.04 on 08/13/24 | 1,109.99 on 08/12/24 | 46.48 on 08/12/24 |
| High | 12.90 on 10/22/21 | 335.66 on 08/30/24 | 500.25 on 08/30/24 | 1,211.20 on 08/27/24 | 50.75 on 09/04/24 |
| 3-Month | |||||
| %Chg | -15.12% since 07/22/21 | +7.44% since 06/11/24 | -3.85% since 06/11/24 | +11.30% since 06/11/24 | +13.34% since 06/11/24 |
| Low | 8.21 on 10/22/21 | 295.30 on 06/13/24 | 458.04 on 08/13/24 | 1,009.15 on 06/12/24 | 39.35 on 07/05/24 |
| High | 12.90 on 10/22/21 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 51.19 on 07/29/24 |
| 6-Month | |||||
| %Chg | -14.75% since 04/22/21 | +17.32% since 03/11/24 | +11.71% since 03/11/24 | +16.62% since 03/11/24 | -10.30% since 03/11/24 |
| Low | 8.21 on 10/22/21 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.35 on 07/05/24 |
| High | 12.90 on 10/22/21 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 124,844 | 176,449,568 | 121,486,200 | 125,209,848 | 99,895,480 |
| Shares Outstanding, K | 14,792 | 536,435 | 258,053 | 110,186 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -10,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 2,645,600,000 | 3,547,100,000 | 12,201,000,000 |
| Last Quarter Net Income | -2,202,161 | 746,000,000 | -3,593,600,000 | 1,432,300,000 | 1,680,000,000 |
| 60-Month Beta | N/A | 0.61 | 0.40 | 0.12 | 0.46 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.97 on 08/06/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 | 2.07 on 07/26/24 |
| Latest Earnings Date | 01/04/18 | 10/29/24 | 11/04/24 | 08/01/24 | 10/24/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.600 on 07/05/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 07/05/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.52 | 0.00 | 29.80 | 35.40 |